Capricor Therapeutics
CAPR
#4848
Rank
โ‚น171.05 B
Marketcap
โ‚น2,974
Share price
6.61%
Change (1 day)
258.07%
Change (1 year)

Earnings for Capricor Therapeutics (CAPR)

Earnings in 2025 (TTM): -โ‚น7.1 Billion

According to Capricor Therapeutics 's latest financial reports the company's current earnings are โ‚น11.13 Million. In 2024 the company made an earning of -โ‚น3.75 Billion a decrease over its 2023 earnings that were of -โ‚น2.07 Billion. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Capricor Therapeutics from 2001 to 2025

Annual earnings

Year Earnings Change
2025 (TTM) -โ‚น7.1 Billion89.38%
2024 -โ‚น3.75 Billion81.57%
2023 -โ‚น2.07 Billion-23.2%
2022 -โ‚น2.69 Billion44.93%
2021 -โ‚น1.86 Billion46.61%
2020 -โ‚น1.27 Billion78.71%
2019 -โ‚น0.71 Billion-49.7%
2018 -โ‚น1.41 Billion-724.78%
2017 โ‚น0.22 B-112.93%
2016 -โ‚น1.75 Billion46.27%
2015 -โ‚น1.2 Billion106.82%
2014 -โ‚น0.58 Billion-48.41%
2013 -โ‚น1.12 Billion977.23%
2012 -โ‚น0.11 Billion-77.11%
2011 -โ‚น0.46 Billion-22.35%
2010 -โ‚น0.59 Billion-20.17%
2009 -โ‚น0.74 Billion-41.17%
2008 -โ‚น1.25 Billion41.05%
2007 -โ‚น0.89 Billion1098.87%
2006 -โ‚น73.41 Million4101.55%
2005 -โ‚น1.75 Million-0.97%
2004 -โ‚น1.77 Million17.87%
2003 -โ‚น1.5 Million3.66%
2002 -โ‚น1.45 Million-30.11%
2001 -โ‚น2.07 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Johnson & Johnson
JNJ
โ‚น3.107 T-41,022.26%๐Ÿ‡บ๐Ÿ‡ธ USA
Neurocrine Biosciences
NBIX
โ‚น58.95 B-876.32%๐Ÿ‡บ๐Ÿ‡ธ USA
Cytokinetics
CYTK
-โ‚น72.72 Billion 857.38%๐Ÿ‡บ๐Ÿ‡ธ USA
Celldex Therapeutics
CLDX
-โ‚น26.62 Billion 250.49%๐Ÿ‡บ๐Ÿ‡ธ USA
Palatin Technologies
PTN
-โ‚น0.45 Billion-94.15%๐Ÿ‡บ๐Ÿ‡ธ USA
Eterna Therapeutics
ERNA
-โ‚น0.88 Billion-88.43%๐Ÿ‡บ๐Ÿ‡ธ USA